SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : WAND (Milestone Scientific)
MS 165.10+0.9%10:00 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PETE STONEY who wrote (702)6/7/2000 2:21:00 PM
From: Ram Seetharaman   of 717
 
Wednesday June 7, 11:15 am Eastern Time
Company Press Release
Milestone Scientific, Inc. Announces FDA Approval for the Use of The Wand in Medical Applications
LIVINGSTON, N.J.--(BUSINESS WIRE)--June 7, 2000--Milestone Scientific, Inc. (AMEX:MS - news) today announced that ``The Wand''©, Milestone's computerized injection system for the administration of virtually painless precision metered dental anesthetic injections, had been approved by the FDA for use in medicine.

Mitchell Kuhn, President and Chief Operating Officer of Milestone, stated, ``We believe that The Wand©'s demonstrated advantages in administering anesthetics in dentistry has applicability in many medical areas, including cosmetic and plastic surgery, colorectal surgery, dermatology, emergency room medicine, obstetrics and gynecology and podiatry. We plan to offer physicians and nurses a series of educational seminars, similar to those we provide to dentists and hygienists. The Wand© will allow the physician to deliver local anesthesia in a virtually painless and safer manner. It will also allow many procedures to be performed on an ambulatory basis which, because of patient discomfort, often had to be performed in a hospital setting under general anesthesia.''

Milestone Scientific Inc. is the developer, manufacturer and marketer of The Wand©, a computer controlled injection system. This precision metered, local anesthetic injection enables virtually painless injections to be administered consistently.

This release contains certain forward-looking statements which involve known and unknown risks, uncertainties or other factors not under the Company's control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include, but are not limited to, those detailed in the Company's periodic filings with the Securities and Exchange Commission.

--------------------------------------------------------------------------------
Contact:

Wolfe Axelrod Weinberger Associates LLC
Stephen D. Axelrod, CFA
Denise Ford (Media)
212/370-4500; 212/370-4505 (Fax)
e-mail: steve@wolfeaxelrod.com
or
Milestone Scientific Inc.
Mitchell G. Kuhn, President
973/535-2717; 973/535-2829 (Fax)
Web site: www.milesci.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext